Posted on August 2nd, 2018by RMANYin Research

Women’s Genetic Signature

RMA is working with a biotechnology company, Celmatix, on a study focused on the genetic and phenotypic risk factors underlying female infertility. The study’s goal is to discover genetic sequences and/or mutations within female patients which may be linked to their fertility. The findings from the study are expected to alleviate genetic risk factors for a number of fertility issues at an earlier stage and foster better treatment regimens for future IVF patients.

To learn more, click here.

The First Step Towards Your Future

Every journey begins with a first step. Attend a free seminar, speak with
a patient concierge, or schedule a consultation.

Get Started

Dec 14th - Virtual Egg Freezing 101 Seminar. Dec 14th - Virtual Egg Freezing 101 Semin…. Learn More